MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?

Mult Scler Relat Disord. 2019 Aug:33:67-69. doi: 10.1016/j.msard.2019.05.021. Epub 2019 May 28.

Abstract

MOG-antibody associated demyelinating disease is a new emerging diagnostic entity. Recently, international recommendations for testing of anti-MOG antibodies were published. Herein, we describe a case of anti-MOG antibody-associated demyelinating disease initially diagnosed as typical MS, and, at presentation, not fulfilling the proposed recommendations. This case highlights the expanding spectrum of anti-MOG antibody-associated demyelinating disease, illustrating the distinct and overlapping features of MS and MOG-antibody associated demyelinating disease, providing evidence that on rare occasions these recommendations may prove too restrictive.

Keywords: Anti-MOG antibodies; Anti-MOG antibody testing; MOG antibody-associated demyelination; Multiple sclerosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Autoantibodies / immunology
  • Autoantigens / immunology
  • Demyelinating Autoimmune Diseases, CNS / diagnosis*
  • Demyelinating Autoimmune Diseases, CNS / immunology*
  • Demyelinating Autoimmune Diseases, CNS / pathology*
  • Diagnosis, Differential
  • Humans
  • Male
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / pathology
  • Myelin-Oligodendrocyte Glycoprotein / immunology*

Substances

  • Autoantibodies
  • Autoantigens
  • MOG protein, human
  • Myelin-Oligodendrocyte Glycoprotein